Clinical Trial Update: Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose [Phase 3]

View source ↗

Summary

Phase 3 study evaluating long-term safety and antibody persistence of the Takeda dengue vaccine (TDV) and the impact of a booster dose, with results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• TDV (Takeda dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Dengue Fever | Phase 3 | Status: COMPLETED | Results posted: 2025-06-12